We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Bayer and Inverness to Develop Heart Test

An agreement to co-develop a test for congestive heart failure and other tests has been announced by Bayer HealthCare Diagnostics Division and Inverness Medical Innovations, Inc. More...
30 Nov -0001

Visitors Pack Medical Fair in China

The China International Medical Equipment Fair (CMEF), held in Chengdu (China) in November 2005, hosted more than 1,770 exhibitors and attracted more than 47,000 professional visitors from 23 countries worldwide during the five days of the fair. More...
30 Nov -0001

Rubicon and Abbott to Develop Cancer Diagnostic

A multi-year research and option agreement has been announced whereby Rubicon Genomics, Inc., and Abbott Molecular will co-develop the MethylPlex methylation detection technology of Rubicon for the diagnosis and prognosis of cancer. More...
30 Nov -0001

GE Gets Distribution Rights to Blood Platform

Under the terms of a new agreement, GE Healthcare has exclusive global distribution rights to Thermogenesis Corp's closed automated AXP system for harvesting mononuclear cells (MNC) from cord blood. More...
30 Nov -0001

Beckman to Buy DSL, Expand Endocrine Testing

In a move to gain leadership in specialty endocrine testing, Beckman Coulter, Inc. has agreed to acquire Diagnostic Systems Laboratories Corp More...
30 Nov -0001

Qiagen to Acquire Chinese Biotech Firm

In a move to expand its presence in China and other growing Asian markets, Qiagen N.V. has agreed to acquire PG Biotech Co. Ltd. for around U.S.$14.5 million in cash. More...
30 Nov -0001

New Technologies Fuel EU Diagnostics Market

Sparked by new technologies and other medical advances, the European in vitro diagnostics (IVD) market is expected to reach U.S.$43 billion in 2011, up from $28.7 billion in 2004, according to a new report from Frost & Sullivan More...
30 Nov -0001
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Histamine ELISA
Histamine ELISA
New
Human Insulin CLIA
Human Insulin CLIA Kit


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.